Mount Yale Investment Advisors, LLC Sangamo Therapeutics, Inc Transaction History

Mount Yale Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $47,550 - $83,000	-5,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$13.05 - $19.05 $43,834 - $63,988	-3,359 Reduced 40.18%	5,000 $72,000
Q2 2018 Aug 22, 2018	BUY	$13.9 - $19.8 $111,144 - $158,320	7,996 Added 2202.75%	8,359 $119,000
Q1 2018 Jun 25, 2018	BUY	$16.7 - $26.35 $6,062 - $9,565	363 New	363 $7,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.